Guaifenesin
NDC 51660-567, Guaifenesin, tablet, extended release, from Ohm Laboratories, Inc..
- Product NDC
- 51660-567
- Status
- Listed
- Labeler
- Ohm Laboratories, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA209254
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51660-567 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN1200 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51660-567-54 | 51660056754 | 14 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-54) |
| 51660-567-58 | 51660056758 | 56 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-58) |
| 51660-567-86 | 51660056786 | 28 TABLET, EXTENDED RELEASE in 1 CARTON (51660-567-86) |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 51660056786
GET /v1/drugs/nadac/51660056786
Use it
Look up 51660-567 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51660-567 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51660-567. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.